The coronavirus outbreak (COVID-19) has helped certain industries in the market to increase their online sales throughout the world.
Hygiene products such as antibacterial gel and cleansers have had a positive impact on sales, compared to 2019, when online orders for cleaning and medical products ranked last. The sales growth of cleaning products is the most noticeable, however. Sales of aerosol disinfectants increased 385.3% year on year.
Sales of hand sanitizers and similar products have swelled across several international markets since the COVID-19 outbreak began. Online stocks of many hand sanitizer gels and COVID-19 related products have sold out at Amazon, Walgreens and Walmart.
There are now more than 23.7 million worlwide and 5.6 million cases of COVID-19 confirmed in the U.S. alone. As that number rises, the need for greater testing capacities and protections related products will continue to increase. Another surge in cases will further boost demand, and that makes Dalrada Financial Corp. (OTC: DFCO) a relatively safe investment during the pandemic.
Last week, Dalrada Financial Corp. (OTC: DFCO) announced the Company’s financial results for the twelve month period ending June 30, 2020 with growth of 1,602% year-over-year. Dalrada achieved $1,228,604 Total Revenues, and a 43% Gross Profit Margin for fiscal year 2020 – this is compared to prior year results of $72,155 Total Revenues in fiscal 2019. The Company will report a net loss due to increased research & development costs, capital expenditures towards production & warehousing facilities, manufacturing of finished goods, inventory and equipment purchases, and marketing of products and services. In the fourth quarter of 2020 ending June 30th, the company recorded $827,797 Total Revenues as compared to $351,324 recorded in the previous quarter ending March 31, 2020.
The increase in performance resulted from distribution and consumer sales of GlanHealth’s alcohol-free sanitizing products and services, Prakat Solutions’ expansion with existing customers and new U.S. opportunities in software and mobile application development services, and Dalrada Precision’s addition of bespoke parts with existing customers including new customer orders. Dalrada will release audited financials in approximately three weeks from this announcement.
Dalrada Health’s primary focus is solving world health problems. The GlanHealth™ revolutionary line of alcohol-free sanitizing products include:
- Hand Sanitizer Foam, Wipes and Spray
- Advanced Sanitizing Soap
- All Purpose Advanced Surface Cleaner
- Antimicrobial Wound & Skin Therapy
- Mold and Mildew Sanitizing & Prevention
- Laundry Sanitizing & Deodorant
As stated in Dalrada’s previous corporate announcement, GlanHealth feels that companies that take shortcuts are short lived – especially newcomers to the sanitizing industry. GlanHealth™ is fulfilling increased global business and consumer demand for alcohol-free sanitizing solutions. GlanHealth™ is committed to following a strategic approach to building a sustainable business model based on purity and consumer trust.